Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

COVID-19 ECMO patients face bleeding and clotting dangers

NCT ID NCT07352072

First seen Jan 29, 2026 · Last updated May 23, 2026 · Updated 12 times

Summary

This study will look back at the medical records of 50 adult ICU patients with COVID-19 who needed a special life support machine (VV-ECMO). The goal is to understand how often these patients have serious bleeding or blood clots, and how blood transfusions and blood thinners affect their outcomes. The findings may help doctors better manage these risks in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of cardiothoracic anaesthsia and intensive care 4141

    Copenhagen, 2100, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.